Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » DermTech Enters Agreement With Blue Cross Blue Shield of Texas for Skin Cancer Assay

DermTech Enters Agreement With Blue Cross Blue Shield of Texas for Skin Cancer Assay

Feb 12, 2021
|
staff reporter

This article has been updated from a previous version to include DermTech's share price in Friday afternoon trading on the Nasdaq.

NEW YORK ─ Skin cancer diagnostic company DermTech this week announced that it has inked a contract that makes its Pigmented Lesion Assay available to approximately 6 million Blue Cross Blue Shield of Texas (BCBSTX) members.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

What's Popular?

In Business News

  1. DiaSorin to Acquire Luminex for $1.8B

  2. Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

  3. 10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit

  4. Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

  5. People in the News: New Appointments at Mission Bio, Akoya Biosciences, Micronoma, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.